Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancer.

MLA

Di Bartolomeo, Maria, et al. “Role of the Antiangiogenic Agent Bevacizumab in the Treatment of Elderly Patients with Metastatic Colorectal Cancer.” Drugs & Aging, vol. 28, no. 2, Feb. 2011, pp. 83–91. EBSCOhost, https://doi.org/10.2165/11584710-000000000-00000.

APA

Di Bartolomeo, M., Pietrantonio, F., Martinetti, A., Buzzoni, R., Gevorgyan, A., & Bajetta, E. (2011). Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancer. Drugs & Aging, 28(2), 83–91. https://doi.org/10.2165/11584710-000000000-00000

Chicago

Di Bartolomeo, Maria, Filippo Pietrantonio, Antonia Martinetti, Roberto Buzzoni, Arpine Gevorgyan, and Emilio Bajetta. 2011. “Role of the Antiangiogenic Agent Bevacizumab in the Treatment of Elderly Patients with Metastatic Colorectal Cancer.” Drugs & Aging 28 (2): 83–91. doi:10.2165/11584710-000000000-00000.